FMS Fresenius Medical Care AG

NYSE · US · Healthcare · Medical Care Facilities · freseniusmedicalcare.com

20.69USD-7.72%Mkt Cap: 11.01B $P/E: 10.661d ago

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and di…

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$26.80BUSDP/E 15.8

THC

Tenet Healthcare Corporation

$20.81BUSDP/E 10.0

EHC

Encompass Health Corporation

$12.30BUSDP/E 20.9

FME

Fresenius Medical Care AG

Universal Health Services, Inc.

$10.44BUSDP/E 7.2

ENSG

The Ensign Group, Inc.

Option Care Health, Inc.

$4.64BUSDP/E 23.5

CON

Concentra Group Holdings Parent, Inc.

$4.64BUSDP/E 23.5

LFST

LifeStance Health Group, Inc.

National HealthCare Corporation

$3.58BUSDP/E 25.7

ACHC

Acadia Healthcare Company, Inc.

$2.70BUSD

AVAH

Aveanna Healthcare Holdings Inc.

$2.67BUSDP/E 9.7

GRDN

Guardian Pharmacy Services, Inc.

$2.61BUSDP/E 40.0

BKD

Brookdale Senior Living Inc.

$2.60BUSD

Pediatrix Medical Group, Inc.

$2.11BUSDP/E 12.4

Key Statistics

Company

Market Cap11.01B USD

Enterprise Value22.82B USD

Revenue (TTM)19.43B USD

Gross Profit5.03B USD

Net Income (TTM)978.37M USD

Revenue/Share34.64 USD

Last Price20.69 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees107.2K

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)10.66

P/E (Forward)7.51

PEG0.74

EV/EBITDA8.39

EV/Revenue1.17

P/S0.61

P/B0.84

EPS (TTM)1.94

EPS (Forward)2.99

52W Range

20.029% of range27.64

52W High27.64 USD

52W Low20.02 USD

Profitability

Gross Margin25.62%

Oper. Margin10.77%

EBITDA Margin14.01%

Profit Margin4.98%

ROE7.35%

ROA3.16%

Growth

Revenue Growth1.40%

Earnings Growth5.50%

Cash Flow & Leverage

Operating CF2.68B USD

CapEx (TTM)915.37M USD

FCF Margin10.41%

FCF Yield18.37%

Net Debt9.92B USD

Net Debt/EBITDA3.64

Balance Sheet

Debt/Equity0.81

Current Ratio1.07

Quick Ratio0.63

Book Value/Sh26.75 USD

Cash/Share1.99 USD

Dividends

Fwd Div Rate0.87 USD

Trail. Div Rate1.49 USD

Div. Yield3.85%

5Y Avg Yield3.14%

Payout Ratio45.01%

Ex-Div DateMay 22, 2026

Pay DateJun 8, 2026

Splits

Last Split2:1

Split DateDec 4, 2012

Analyst Consensus

Rating3.4 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)23.55 USD

Upside (mean)+13.8%

Target Range16.90 USD – 37.17 USD

16.90+13.8% to mean37.17

# Analysts7

Ownership

Shares Out.532.22M

Float397.12M

Insiders0.00%

Institutions9.86%

Short Interest

Short Ratio4.5d

Short % Out.0.52%

Shares Short2.75M

Short (prev mo.)2.77M

Technical

SMA 5023.28 (-11.1%)

SMA 20023.02 (-10.1%)

Beta0.81

S&P 52W Chg15.78%

Avg Vol (30d)781.39K

Avg Vol (10d)789.05K

Technical Indicators

RSI (14)45.9

MACD-0.1788

MACD Signal-0.2257

MACD Hist.+0.0469

BB Upper23.03 USD

BB Middle22.47 USD

BB Lower21.90 USD

BB Width5.01%

ATR (14)0.3675 USD

Vol Ratio (20d)0.91x